Clinical Trial Update: Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating CHS-006 in combination with toripalimab for advanced solid tumors, including non-small cell lung cancer, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• CHS-006
• Toripalimab (Toripalimab)

Snippet

Sponsor: Coherus Oncology, Inc. | Conditions: Advanced Solid Tumor, Non-Small Cell Lung Cancer | Phase 1 | Status: TERMINATED